Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-28 Sale | 2024-02-29 4:17 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 574 | $155.3 | $89,145 | 13,163 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-20 4:09 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,308 | $148.06 | $193,666 | 8,013 (Indirect Direct) | View |
| 2023-08-04 Sale | 2023-08-07 6:05 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 7,627 | $184.78 | $1,409,306 | 5,026 (Indirect Direct) | View |
| 2023-04-27 Sale | 2023-04-28 5:54 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 4,294 | $197.12 | $846,450 | 5,026 (Indirect Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:07 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 18,072 | $200 | $3,614,400 | 5,026 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 4:21 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 14,030 | $0 | 23,377 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:17 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,908 | $0 | 13,163 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 4,295 | $0 | 8,013 (Direct) | View |
| 2023-08-03 Option Award | 2023-08-07 6:05 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 7,627 | $0 | 5,026 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:43 pm | N/A 2033-06-13 | SQZ Biotechnologies Co | SQZ | Garg Pushkal Director | 39,875 | $0 | 39,875 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 5:54 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 4,294 | $0 | 5,026 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 4:07 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 2,500 | $96.45 | 5,026 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 4:07 pm | 2018-08-11 2024-12-17 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 5,000 | $0 | 5,026 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:22 pm | N/A 2026-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 17,574 | $0 | 17,574 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 165 | $205.87 | 18,098 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 146 | $210.02 | 18,098 (Direct) | View |
| 2022-08-03 Option Award | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 11,311 | $0 | 18,098 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 172 | $209.91 | 18,098 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 4,603 | $189.76 | 18,098 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:01 pm | N/A 2032-06-14 | SQZ Biotechnologies Co | SQZ | Garg Pushkal Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:12 pm | N/A 2032-02-22 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 24,128 | $0 | 24,128 (Direct) | View |
Ownership | 2022-01-04 4:03 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 0 | $0 | 186,411 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 5:16 pm | N/A 2031-06-14 | SQZ Biotechnologies Co | SQZ | Garg Pushkal Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 6:35 pm | N/A 2030-10-28 | SQZ Biotechnologies Co | SQZ | Garg Pushkal Director | 7,055 | $0 | 7,055 (Direct) | View |
Ownership | 2020-10-29 8:51 pm | N/A 2028-11-06 | SQZ Biotechnologies Co | SQZ | Garg Pushkal Director | 0 | $0 | 44,752 (Direct) | View |